Table 4.
Effects of Cordycepin, Cisplatin, and Their Combinations on Ishikawa Cell Cycle
| Compounds (Concentration) | G0/G1 | S | G2 |
|---|---|---|---|
| Control | 42.4% ± 2.3% | 46.3% ± 3.6% | 11.4% ± 1.5% |
| Cordycepin (12.5 μg/ml) | 57.9% ± 3.4% | 29.4% ± 1.1% | 12.9% ± 2.9% |
| Cordycepin (25 μg/ml) | 57.6% ± 3.6% | 31.1% ± 3.5% | 11.5% ± 2.7% |
| Cisplatin (0.5 μg/ml) | 11.1% ± 0.1% | 63.2% ± 1.4% | 25.7% ± 1.4% |
| Cisplatin (1 μg/ml) | 5.1% ± 2.4% | 72.4% ± 2.5% | 22.6% ± 4.9% |
| Cisplatin (2 μg/ml) | 4.9% ± 4.4% | 80.5% ± 1.2% | 14.6% ± 3.3% |
| Cordycepin (12.5 μg/ml) plus cisplatin (0.5 μg/ml) | 10.7% ± 1.5% | 77.9% ± 4.3% | 11.5% ± 5.7% |
| Cordycepin (12.5 μg/ml) plus cisplatin (1 μg/ml) | 7.5% ± 3.5% | 80.7% ± 2.2% | 11.8% ± 4.4% |
| Cordycepin (25 μg/ml) plus cisplatin (0.5 μg/ml) | 13.5% ± 0.7% | 71.4% ± 2.6% | 15.1% ± 2.2% |
| Cordycepin (25 μg/ml) plus cisplatin (1 μg/ml) | 14.5% ± 0.7% | 82.7% ± 1.7% | 2.8% ± 1.9% |